Orient Biotech(688298.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Orient Biotech
688298.SH
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagnosis; and quantum-beads multiplex. Zhejiang Orient Gene Biotech Co., Ltd was founded in 2005 and is based in Huzhou, China.
1.470 T
688298.SHMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
C
BiotechnologyIndustry
Industry Ranking53/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-8.89%D
    • Profit Margin-54.56%E
    • Gross Margin42.89%B
  • Growth ScoreB
    • Revenue YoY20.88%B
    • Net Profit YoY4.35%C
    • Total Assets YoY-11.16%E
    • Net Assets YoY-10.20%D
  • Cash ScoreC
    • Cash Flow Margin30.57%D
    • OCF YoY20.88%B
  • Operating ScoreE
    • Turnover0.14E
  • Debt ScoreA
    • Gearing Ratio13.18%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

    Wallstreetcn·
    SH
    688317
    -5.77%
    SZ
    002022
    -3.23%
    SZ
    301080
    0.00%
    Wallstreetcn·
    SH
    688317
    -5.77%
    SZ
    002022
    -3.23%
    SZ
    301080
    0.00%

    Orient Biotech's subsidiary has obtained registration certificates for two medical device products

    Zhitong·
    SH
    688298
    -0.09%
    Zhitong·
    SH
    688298
    -0.09%

    Orient Biotech: Completed the repurchase of 1.8013 million shares

    Zhitong·
    SH
    688298
    -0.09%
    Zhitong·
    SH
    688298
    -0.09%

    Orient Biotech's subsidiary obtains medical device registration certificate

    Zhitong·
    SH
    688298
    -0.09%
    Zhitong·
    SH
    688298
    -0.09%

    Orient Biotech: Net loss of 163 million yuan in the first half of 2025

    Zhitong·
    SH
    688298
    -0.09%
    Zhitong·
    SH
    688298
    -0.09%
    © 2026 Longbridge｜Disclaimer